祝之明. 代谢综合征的临床特征与发病机制[J]. 第三军医大学学报, 2009, 31(1): 17-20.？ [2]杨小君, 许良, 王丰效. 我国学生营养健康状况未来5年发展趋势预测[J]. 第三军医大学学报, 2011, 33(10): 1056-1060.？ [3]Jakobsen M U, Berentzen T, Sorensen T I, et al. Abdominal obesity and fatty liver[J]. Epidemiol Rev, 2007, 29: 77-87.？ [4]Lafontan M, Berlan M. Do regional differences in adipocyte biology provide new pathophysiological insights?[J]. Trends Pharmacol Sci, 2003, 24(6): 276-283.？ [5]Gastaldelli A, Cusi K, Pettiti M, et al. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects[J]. Gastroenterology, 2007, 133(2): 496-506.？ [6]Kotronen A, Yki-Jarvinen H, Sevastianova K, et al. Comparison of the relative contributions of intra-abdominal and liver fat to components of the metabolic syndrome[J]. Obesity(Silver Spring), 2011, 19(1): 23-28. [7]Fabbrini E, Magkos F, Mohammed B S, et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity[J]. Proc Natl Acad Sci U S A, 2009, 106(36): 15430-15435.？ [8]Fabbrini E, Tamboli R A, Magkos F, et al. Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults[J]. Gastroenterology, 2010, 139(2): 448-455.？ [9]Recio-Rodriguez J I, Gomez-Marcos M A, Patino-Alonso M C, et al. Abdominal obesity vs general obesity for identifying arterial stiffness, subclinical atherosclerosis and wave reflection in healthy, diabetics and hypertensive[J]. BMC Cardiovasc Disord, 2012, 12: 3. [10]Gast K B, Smit J W, den-Heijer M, et al. Abdominal adiposity largely explains associations between insulin resistance, hyperglycemia and subclinical atherosclerosis: the NEO study[J]. Atherosclerosis, 2013, 229(2): 423-429.？ [11]Liu J J, Sum C F, Tavintharan S, et al. Obesity is a determinant of arterial stiffness independent of traditional risk factors in Asians with young-onset type 2 diabetes[J]. Atherosclerosis, 2014, 236(2): 286-291.？ [12]Huang Y, Bi Y, Xu M, et al. Nonalcoholic fatty liver disease is associated with atherosclerosis in middle-aged and elderly Chinese[J]. Arterioscler Thromb Vasc Biol, 2012, 32(9): 2321-2326.？ [13]Gastaldelli A, Kozakova M, Hojlund K, et al. Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population[J]. Hepatology, 2009, 49(5): 1537-1544. [14]Gaggini M, Morelli M, Buzzigoli E, et al. Non-alcoholic fatty liver disease(NAFLD) and its connection with insulin resistance, dyslipidemia,？ atherosclerosis and coronary heart disease[J]. Nutrients, 2013, 5(5): 1544-1560.？ [15]Weisell R C. Body mass index as an indicator of obesity[J]. Asia Pac J Clin Nutr, 2002, 11(Suppl 8): S681-S684.？ [16]Shimizu Y, Nakazato M, Sekita T, et al. Association of arterial stiffness and diabetes with triglycerides-to-HDL cholesterol ratio for Japanese men: the Nagasaki Islands Study[J]. Atherosclerosis, 2013, 228(2): 491-495.？ [17]Hu H, Cui H, Han W, et al. A cutoff point for arterial stiffness using the cardio-ankle vascular index based on carotid arteriosclerosis[J]. Hypertens Res, 2013, 36(4): 334-341.？ [18]Horinaka S, Yagi H, Ishimura K, et al. Cardio-ankle vascular index(CAVI) correlates with aortic stiffness in the thoracic aorta using ECG-gated multi-detector row computed tomography[J]. Atherosclerosis, 2014, 235(1): 239-245.？ [19]Liu C J. Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese[J]. J Gastroenterol Hepatol, 2012, 27(10): 1555-1560. ？
[2]
高燕翔,张勇,刘裕,等.SREBP-1c在白藜芦醇预防大鼠非酒精性脂肪肝发生中的作用[J].第三军医大学学报,2015,37(17):1704. Gao Yanxiang,Zhang Yong,Liu Yu,et al.SREBP-1c is involved in preventive effect of resveratrol on pathogenesis of nonalcoholic fatty liver disease in rats[J].J Third Mil Med Univ,2015,37(06):1704. [2]杨朝霞,代东伶,沈薇.虫草菌丝和还原型谷胱甘肽对非酒精性脂肪肝大鼠模型治疗效果的研究[J].第三军医大学学报,2007,29(22):2176. YANG Zhao-xia,DAI Dong-ling,SHEN Wei.Effect of cordyceps sinensis and reduced glutathione on experimental mouse model with non-alcoholic fatty liver disease[J].J Third Mil Med Univ,2007,29(06):2176. [3]史洪涛,李陶,陈东风.肝细胞色素氧化酶Ⅰ在非酒精性脂肪肝大鼠形成中的作用[J].第三军医大学学报,2006,28(02):160. [4]房殿亮,宁波,沈薇,等.干扰SREBP-1c对内质网应激状态下L02和HepG2肝细胞脂质沉积的影响[J].第三军医大学学报,2013,35(06):513. Fang Dianliang,Ning Bo,Shen Wei,et al.SREBP-1c gene interference decreases lipid accumulation in L02 and HepG2 hepatocytes under endoplasmic reticulum stress[J].J Third Mil Med Univ,2013,35(06):513. [5]王万东,陈东风.非酒精性脂肪变性肝细胞模型中ATF4基因的表达及其意义[J].第三军医大学学报,2010,32(14):1487. Wang Wandong,Chen Dongfeng.Expression and significance of activating transcription factor 4 in oleic acid-induced hepatocyte steatosis in vitro[J].J Third Mil Med Univ,2010,32(06):1487. [6]周婷婷,秦波,郑天鹏,等.非酒精性脂肪肝患者血浆FGF21水平及与肥胖、胰岛素抵抗关系研究[J].第三军医大学学报,2010,32(03):265. Zhou Tingting,Qin Bo,Zheng Tianpeng,et al.Correlation between plasma fibroblast growth factor 21 level, obesity and insulin resistance in nonalcoholic fatty liver disease patients[J].J Third Mil Med Univ,2010,32(06):265. [7]曾志华,曾明慧,冯雯琪,等.电针阻断胰岛素抵抗及过氧化反应治疗非酒精性脂肪肝的实验研究[J].第三军医大学学报,2008,30(11):1055. ZENG Zhi-hua,ZENG Ming-hui,FENG Wen-qi,et al.Electroacupuncture treats rat non-alcoholic fatty liver by blocking insulin resistance and peroxidation[J].J Third Mil Med Univ,2008,30(06):1055. [8]邱烈旺,顾陆昀,吕琳,等.水甘油通道蛋白在非酒精性脂肪变性肝细胞模型中的表达及意义[J].第三军医大学学报,2012,34(07):622. Qiu Liewang,Gu Luyun,Lu Lin,et al.Expression of aquaglyceroporins in nonalcoholic hepatocyte steatosis and its significance[J].J Third Mil Med Univ,2012,34(06):622. [9]肖凯,朱晟易,童钰铃,等.普洱茶水提取物对大鼠非酒精性脂肪性肝病的干预作用[J].第三军医大学学报,2013,35(18):1992. [10]代雪枫,陈东风.非酒精性脂肪肝再生信号转导异常的研究进展[J].第三军医大学学报,2005,27(22):2295.
